Europe’s medical devices industry saw a drop of 33.33% in deal activity during February 2021, when compared with the last 12-month average, led by Ally Bridge Group, Fountain Healthcare Partners, KCK Group and Sofinnova Partners‘ $108m acquisition of Mainstay Medical International, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

 

A total of 22 medical devices industry deals worth $196.81m were announced for the region in February 2021, against the 12-month average of 33 deals.

Of all the deal types, venture financing saw most activity in February 2021 with 15 transactions, representing a 68.2% share for the region.

In second place was M&A with five deals, followed by private equity deals with two transactions, respectively capturing a 22.7% and 9.1% share of the overall deal activity for the month.

In terms of value of deals, private equity was the leading category in Europe’s medical devices industry with $123.48m, followed by venture financing deals totalled $73.33m.

Europe medical devices industry deals in February 2021: Top deals

The top five medical devices deals accounted for 86.8% of the overall value during February 2021.

The combined value of the top five medical devices deals stood at $170.77m, against the overall value of $196.81m recorded for the month.

The top five medical devices industry deals of February 2021 tracked by GlobalData were:

1) Ally Bridge Group, Fountain Healthcare Partners, KCK Group and Sofinnova Partners’ $108m private equity deal with Mainstay Medical International

2) The $21.77m venture financing deal with Medlumics by Andera Partners, Asabys Partners, Caixa Capital Risc SGEIC, Center for the Development of Industrial Technology, Innogest Capital II and VI Partners

3) MIG Fonds, Salvia and Wellington Partners Venture Capital’s $18.23m venture financing of Creative Balloons

4) The $15.48m private equity deal with Devyser Diagnostics by Swedbank Robur and The Fourth Swedish National Pension Fund

5) BGF Investment Management’s venture financing of Vasorum for $7.29m.